Although direct evidence in glioma is limited, studies in other cancers (e.g., neuroblastoma) suggest that TRPM6 expression can be upregulated by oncogenes such as N-Myc, thereby influencing ionic balance and cell proliferation [47]. This evidence concerns the gene MYCN and central nervous system cancer.